Business Context and Reporting Period
This Form 8-K Current Report was filed by MediciNova, Inc. on October 5, 2009, covering events occurring on September 29, 2009. The filing addresses a change in the company's independent registered public accounting firm.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Dismissal of Auditor: The Audit Committee approved the dismissal of Ernst & Young LLP (E&Y) as the independent registered public accounting firm effective September 29, 2009.
- Engagement of New Auditor: The Audit Committee approved the engagement of KPMG LLP as the new independent registered public accounting firm effective September 29, 2009.
- Audit History: E&Y's audit reports for the years ended December 31, 2007, and 2008 did not contain adverse opinions, disclaimers, or qualifications regarding uncertainty, audit scope, or accounting principles. The 2007 report included an explanatory paragraph regarding the adoption of SFAS No. 123R.
- No Disagreements: The company reported no disagreements with E&Y on accounting principles, practices, or auditing scope during the two fiscal years ended December 31, 2008, and the interim period through September 29, 2009.
- No Reportable Events: There were no reportable events as defined in Item 304(a)(1)(v) of Regulation S-K during the relevant periods.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary on business operations. It confirms that no consultations were held with KPMG regarding accounting principles or audit opinions prior to their engagement. The primary risk disclosed is the transition of the external audit function, though the company asserts the change was not due to accounting disagreements.
Investor Verification Checklist
- Verify the reasons for the auditor change by reviewing the attached letter from Ernst & Young LLP (Exhibit 16.1).
- Confirm the effective date of KPMG LLP's engagement for future audit cycles.
- Review the company's most recent 10-K or 10-Q filings for the actual financial performance metrics not included in this 8-K.
- Monitor subsequent filings for any restatements or changes in accounting policies following the auditor transition.